Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations (Q30751781)

26 June 2017

1 reference

title

Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations (English)

1 reference

26 June 2017

0 references

0 references

0 references

Eleftherios P. Diamandis

series ordinal

1

object named as

Eleftherios P Diamandis

1 reference

26 June 2017

publication date

28 February 2004

1 reference

Molecular & Cellular Proteomics

26 June 2017

published in

1 reference

26 June 2017

volume

3

1 reference

26 June 2017

issue

4

1 reference

26 June 2017

page(s)

367-378

1 reference

The case for early detection

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in clinical chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Regulated transport of the glucose transporter GLUT4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Clinical proteomics: translating benchside promise into bedside reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Tandem mass spectrometry in the clinical chemistry laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

21 January 2018

Test methods: anabolics

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Mass spectrometry-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Screening for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Osteopontin as a potential diagnostic biomarker for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

The new human tissue kallikrein gene family: structure, function, and association to disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Characterization of Renal Allograft Rejection by Urinary Proteomic Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Re: Serum proteomic patterns for detection of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Serum proteomic patterns for detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Diagnostic potential of serum proteomic patterns in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Putative protein markers in the sera of men with prostatic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Proteomics. Public projects gear up to chart the protein landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Global analysis of protein expression in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

A data review and re-assessment of ovarian cancer serum proteomic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Clinical proteomics: Written in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400007-MCP200

10.1074/MCP.R400007-MCP200

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference